Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Features of intrathecal immunoglobulins in patients with multiple sclerosis.
Di Pauli F, Gredler V, Kuenz B, Lutterotti A, Ehling R, Gneiss C, Schocke M, Deisenhammer F, Reindl M, Berger T. Di Pauli F, et al. Among authors: kuenz b. J Neurol Sci. 2010 Jan 15;288(1-2):147-50. doi: 10.1016/j.jns.2009.09.016. Epub 2009 Oct 13. J Neurol Sci. 2010. PMID: 19828154
Olfactory threshold is impaired in early, active multiple sclerosis.
Lutterotti A, Vedovello M, Reindl M, Ehling R, DiPauli F, Kuenz B, Gneiss C, Deisenhammer F, Berger T. Lutterotti A, et al. Among authors: kuenz b. Mult Scler. 2011 Aug;17(8):964-9. doi: 10.1177/1352458511399798. Epub 2011 Mar 3. Mult Scler. 2011. PMID: 21372115
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Lutterotti A, Kuenz B, Gredler V, Khalil M, Ehling R, Gneiss C, Egg R, Deisenhammer F, Berger T, Reindl M. Lutterotti A, et al. Among authors: kuenz b. J Neuroimmunol. 2006 Dec;181(1-2):145-9. doi: 10.1016/j.jneuroim.2006.09.002. Epub 2006 Oct 13. J Neuroimmunol. 2006. PMID: 17046070
Diagnostic biomarkers in multiple sclerosis.
Kuenz B, Deisenhammer F, Berger T, Reindl M. Kuenz B, et al. Expert Opin Med Diagn. 2007 Oct;1(2):225-33. doi: 10.1517/17530059.1.2.225. Expert Opin Med Diagn. 2007. PMID: 23489309
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
Ehling R, Di Pauli F, Lackner P, Rainer C, Kraus V, Hegen H, Lutterotti A, Kuenz B, De Zordo T, Schocke M, Glatzl S, Löscher WN, Deisenhammer F, Reindl M, Berger T. Ehling R, et al. Among authors: kuenz b. J Neuroimmunol. 2015 Oct 15;287:98-105. doi: 10.1016/j.jneuroim.2015.08.004. Epub 2015 Aug 10. J Neuroimmunol. 2015. PMID: 26439969 Clinical Trial.
20 results